Effect of LCZ696 and Its Components Sacubitril and Valsartan on Insulin Secretion and Glucose Homeostasis in Mice

被引：0
|
作者：
Esser, Nathalie
Schmidt, Christine R.
Barrow, Breanne
Cronic, Laura
Hackney, Daryl J.
Mongovin, Steve M.
Hull, Rebecca L.
Zraika, Sakeneh
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-1797-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1797-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Antihypertensive Efficacy of LCZ696 (Sacubitril/Valsartan) in Hypertension
    Tocci, Giuliano
    CARDIOLOGY, 2020, 145 (09) : 599 - 600
  • [2] Sacubitril/valsartan (LCZ696) for the treatment of heart failure
    Gori, Mauro
    Senni, Michele
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2016, 14 (02) : 145 - 153
  • [3] Cardioprotective effect of LCZ696 (sacubitril/valsartan) experimental acute myocardial infarction
    Ishii, M.
    Kaikita, K.
    Sato, K.
    Sueta, D.
    Fujisue, K.
    Oimatsu, Y.
    Mitsuse, T.
    Hokimoto, S.
    Ogawa, H.
    Tsujita, K.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1412 - 1412
  • [4] LCZ696 (Sacubitril/Valsartan) Can We Predict Who Will Benefit?
    Dec, G. William
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (19) : 2072 - 2074
  • [5] Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor
    Ayalasomayajula, Surya P.
    Langenickel, Thomas H.
    Jordaan, Pierre
    Zhou, Wei
    Chandra, Priyamvada
    Albrecht, Diego
    Pal, Parasar
    Rajman, Iris
    Sunkara, Gangadhar
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (09) : 1065 - 1073
  • [6] LCZ696 ( Valsartan/Sacubitril) - A Possible New Treatment for Hypertension and Heart Failure
    Andersen, Mathilde Borring
    Simonsen, Ulf
    Wehland, Markus
    Pietsch, Jessica
    Grimm, Daniela
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 118 (01) : 14 - 22
  • [7] Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor
    Surya P. Ayalasomayajula
    Thomas H. Langenickel
    Pierre Jordaan
    Wei Zhou
    Priyamvada Chandra
    Diego Albrecht
    Parasar Pal
    Iris Rajman
    Gangadhar Sunkara
    European Journal of Clinical Pharmacology, 2016, 72 : 1065 - 1073
  • [8] The effect of LCZ696 (sacubitril/valsartan) on amyloid-β concentrations in cerebrospinal fluid in healthy subjects
    Langenickel, Thomas H.
    Tsubouchi, Chiaki
    Ayalasomayajula, Surya
    Pal, Parasar
    Valentin, Marie-Anne
    Hinder, Markus
    Jhee, Stanford
    Gevorkyan, Hakop
    Rajman, Iris
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 81 (05) : 878 - 890
  • [9] Development of hybrid spectrofluorimetric method for simultaneous determination of Valsartan and Sacubitril in LCZ696 tablets
    Youssef, Rasha M.
    El-Nahass, Sara A.
    Soliman, Sobhi A.
    Younis, Sameh E.
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2021, 256
  • [10] Pharmacokinetics and safety of sacubitril/valsartan (LCZ696) in patients with mild and moderate hepatic impairment
    Kulmatycki, Kenneth M.
    Langenickel, Thomas
    Ng, Wai Hong
    Pal, Parasar
    Zhou, Wei
    Lin, Tsu-Han
    Rajman, Iris
    Chandra, Priyamvada
    Sunkara, Gangadhar
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (09) : 728 - 739
12345